thiazolyl blue has been researched along with Cholangiocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, SY; Kim, EY; Kim, SH; Lee, SS; Shin, DH; Shin, JH | 1 |
| Gu, X; Yang, W; Zhang, J; Zhang, T; Zhao, Y; Zheng, Z | 1 |
2 other study(ies) available for thiazolyl blue and Cholangiocarcinoma
| Article | Year |
|---|---|
Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Disease Models, Animal; Heterografts; Humans; Mice, Inbred BALB C; Mice, Nude; Oxides; Staining and Labeling; Tetrazolium Salts; Thiazoles; Treatment Outcome | 2014 |
The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Flow Cytometry; Formazans; Gene Expression Profiling; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Staining and Labeling; Tetrazolium Salts; Thiazoles | 2013 |